The activity of c-myb antisense oligonucleotide to prevent intimal hyperplasia is nonspecific.

Castier, Y; Chemla, E; Nierat, J; Heudes, D; Vasseur, M A; Rajnoch, C; Bruneval, P; Carpentier, A; Fabiani, J N

Castier, Y; Chemla, E; Nierat, J; Heudes, D; Vasseur, M A; Rajnoch, C; Bruneval, P; Carpentier, A; Fabiani, J N.

Affiliation

Castier Y; Department of Cardiovascular Surgery, Broussais Hospital, Paris, France.

J Cardiovasc Surg (Torino) ; 39(1): 1-7, 1998 Feb.

Article in En | MEDLINE | ID: mdl-9537527

Subject(s)

Aorta, Abdominal/injuries; DNA-Binding Proteins/genetics; Muscle, Smooth, Vascular/drug effects; Oligonucleotides, Antisense/pharmacology; Proto-Oncogene Proteins/genetics; Trans-Activators/genetics; Animals; Cell Division; Double-Blind Method; Hyperplasia/prevention & control; Male; Muscle, Smooth, Vascular/pathology; Proto-Oncogene Proteins c-myb; Random Allocation; Rats; Rats, Wistar; Tunica Intima/pathology

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Aorta, Abdominal / Trans-Activators / Oligonucleotides, Antisense / Proto-Oncogene Proteins / DNA-Binding Proteins / Muscle, Smooth, Vascular Type of study: Guideline / Prognostic_studies Limits: Animals Language: En Year: 1998 Type: Article

Search on Google

XML

PubMed Links